57 results
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
of the statutory formula, also referred to as the Sustainable Growth Rate, for clinician payment and established a quality payment incentive program, also … Models, or APMs, and the Merit-based Incentive Payment System, or MIPS.The full impact to overall physician reimbursement under the Medicare program
F-3
EX-4.1
OBSVF
ObsEva SA
9 Dec 22
Shelf registration (foreign)
7:06am
or of one of its subsidiaries according to one or several equity incentive plans adopted by the board of directors; e) the acquisition of companies … or consultants of the company or of one of its subsidiaries under the terms of one or more equity incentive plans or regulations adopted by the board
F-3
OBSVF
ObsEva SA
9 Dec 22
Shelf registration (foreign)
7:06am
value CHF 1/13 per share, in connection with our equity incentive plans.
Under our articles of association, as amended on December 8, 2022, our share … of its subsidiaries under the terms of one or more equity incentive plans or regulations adopted by the board of directors. Further, our shareholders
6-K
OBSVF
ObsEva SA
1 Dec 22
Index to Unaudited Condensed Consolidated Financial Statements
4:15pm
payment incentive program, also referred to as the Quality Payment Program. This program provides clinicians with two ways to participate, including … through the Advanced Alternative Payment Models, or APMs, and the Merit-based Incentive Payment System, or MIPS. In November 2019, CMS issued a final
6-K
EX-99.1
OBSVF
ObsEva SA
19 May 22
ObsEva SA Announces that Shareholders Approved all Board Proposals at its
7:05am
the proposed increase of ObsEva SA’s Conditional Share Capital for Equity Plans
Shareholders approved the proposed change to ObsEva SA’s Equity Incentive
6-K
l1ca7iq1xkc kinvq
17 May 22
Index to Unaudited Condensed Consolidated Financial Statements
7:00am
6-K
EX-99.1
v8cpfzhsszfz4c c6n2
7 Apr 22
ObsEva Annual General Meeting 2022
7:01am
424B7
yo8l0va
3 Mar 22
Prospectus with selling stockholder info
4:43pm
S-8
EX-5.1
eyfoqgkpfxygblu
2 Mar 22
Registration of securities for employees
4:48pm
S-8
p58zxb9dwi0
2 Mar 22
Registration of securities for employees
4:48pm
S-8
rioirvwulezcqa0
2 Mar 22
Registration of securities for employees
4:48pm
F-3
ku0hahqhp hz92
17 Feb 22
Shelf registration (foreign)
4:14pm
F-3
EX-4.1
0uwpa0wb0 ny7afdsg
17 Feb 22
Shelf registration (foreign)
4:14pm
6-K
EX-99.3
mm2 j6u0mcc
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
424B7
ci2m1e
23 Nov 21
Prospectus with selling stockholder info
4:06pm
F-3
ub3ln3mooh 9u
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K/A
EX-99.2
jgi80 fdieg74cbm
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
168788u6 kf
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
q4hadew66v uob
1 Jun 21
ObsEva SA Announces that Shareholders Approved all Board Proposals at its
6:30am